158 related articles for article (PubMed ID: 24425307)
1. Clinical significance of the ubiquitin ligase UBE3C in hepatocellular carcinoma revealed by exome sequencing.
Jiang JH; Liu YF; Ke AW; Gu FM; Yu Y; Dai Z; Gao Q; Shi GM; Liao BY; Xie YH; Fan J; Huang XW; Zhou J
Hepatology; 2014 Jun; 59(6):2216-27. PubMed ID: 24425307
[TBL] [Abstract][Full Text] [Related]
2. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
3. As an independent prognostic factor, FAT10 promotes hepatitis B virus-related hepatocellular carcinoma progression via Akt/GSK3β pathway.
Liu L; Dong Z; Liang J; Cao C; Sun J; Ding Y; Wu D
Oncogene; 2014 Feb; 33(7):909-20. PubMed ID: 23812429
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin ligase UBE3C promotes melanoma progression by increasing epithelial-mesenchymal transition in melanoma cells.
Tang L; Yi XM; Chen J; Chen FJ; Lou W; Gao YL; Zhou J; Su LN; Xu X; Lu JQ; Ma J; Yu N; Ding YF
Oncotarget; 2016 Mar; 7(13):15738-46. PubMed ID: 26894856
[TBL] [Abstract][Full Text] [Related]
5. Early molecular and genetic determinants of primary liver malignancy.
Feitelson MA; Pan J; Lian Z
Surg Clin North Am; 2004 Apr; 84(2):339-54. PubMed ID: 15062649
[TBL] [Abstract][Full Text] [Related]
6. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma and hepatitis B virus.
Chan HL; Sung JJ
Semin Liver Dis; 2006 May; 26(2):153-61. PubMed ID: 16673293
[TBL] [Abstract][Full Text] [Related]
8. Influence of hepatitis B virus reactivation on the recurrence of HBV-related hepatocellular carcinoma after curative resection in patients with low viral load.
Sohn W; Paik YH; Cho JY; Ahn JM; Choi GS; Kim JM; Kwon CH; Joh JW; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
J Viral Hepat; 2015 Jun; 22(6):539-50. PubMed ID: 25377516
[TBL] [Abstract][Full Text] [Related]
9. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.
Kim MY; Park E; Park JH; Park DH; Moon WS; Cho BH; Shin HS; Kim DG
Oncogene; 2001 Jul; 20(33):4568-75. PubMed ID: 11494152
[TBL] [Abstract][Full Text] [Related]
10. Prediction of hepatocellular carcinoma development by plasma ADAMTS13 in chronic hepatitis B and C.
Ikeda H; Tateishi R; Enooku K; Yoshida H; Nakagawa H; Masuzaki R; Kondo Y; Goto T; Shiina S; Kume Y; Tomiya T; Inoue Y; Nishikawa T; Ohtomo N; Tanoue Y; Ono T; Koike K; Yatomi Y
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2204-11. PubMed ID: 21876190
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin-protein ligase E3C promotes glioma progression by mediating the ubiquitination and degrading of Annexin A7.
Pan SJ; Zhan SK; Ji WZ; Pan YX; Liu W; Li DY; Huang P; Zhang XX; Cao CY; Zhang J; Bian LG; Sun B; Sun QF
Sci Rep; 2015 Jun; 5():11066. PubMed ID: 26067607
[TBL] [Abstract][Full Text] [Related]
12. Nuclear expression of the ubiquitin ligase seven in absentia homolog (SIAH)-1 induces proliferation and migration of liver cancer cells.
Brauckhoff A; Malz M; Tschaharganeh D; Malek N; Weber A; Riener MO; Soll C; Samarin J; Bissinger M; Schmidt J; Longerich T; Ehemann V; Schirmacher P; Breuhahn K
J Hepatol; 2011 Nov; 55(5):1049-57. PubMed ID: 21356256
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma.
Yeh CT; Shen CH; Tai DI; Chu CM; Liaw YF
Oncogene; 2000 Nov; 19(46):5213-20. PubMed ID: 11077437
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma.
Wu JC; Huang YH; Chau GY; Su CW; Lai CR; Lee PC; Huo TI; Sheen IJ; Lee SD; Lui WY
J Hepatol; 2009 Nov; 51(5):890-7. PubMed ID: 19747749
[TBL] [Abstract][Full Text] [Related]
15. Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus.
Hung CH; Hu TH; Lu SN; Kuo FY; Chen CH; Wang JH; Huang CM; Lee CM; Lin CY; Yen YH; Chiu YC
Int J Cancer; 2016 Feb; 138(3):714-20. PubMed ID: 26264553
[TBL] [Abstract][Full Text] [Related]
16. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
Marotta F; Vangieri B; Cecere A; Gattoni A
Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
[TBL] [Abstract][Full Text] [Related]
17. Exome capture sequencing reveals new insights into hepatitis B virus-induced hepatocellular carcinoma at the early stage of tumorigenesis.
Chen Y; Wang L; Xu H; Liu X; Zhao Y
Oncol Rep; 2013 Oct; 30(4):1906-12. PubMed ID: 23912677
[TBL] [Abstract][Full Text] [Related]
18. Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China.
Guo X; Jin Y; Qian G; Tu H
J Hepatol; 2008 Nov; 49(5):718-25. PubMed ID: 18801591
[TBL] [Abstract][Full Text] [Related]
19. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.
Lunn RM; Zhang YJ; Wang LY; Chen CJ; Lee PH; Lee CS; Tsai WY; Santella RM
Cancer Res; 1997 Aug; 57(16):3471-7. PubMed ID: 9270015
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin-protein ligase E3C maintains non-small-cell lung cancer stemness by targeting AHNAK-p53 complex.
Gu J; Mao W; Ren W; Xu F; Zhu Q; Lu C; Lin Z; Zhang Z; Chu Y; Liu R; Ge D
Cancer Lett; 2019 Feb; 443():125-134. PubMed ID: 30503554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]